Deracin^® cleared for use with Denagard^®

Approval gives swine industry new choice for treatment of dysentery, enteritis and pneumonia.

Wilmington, N.C. [June 18, 2019] – Pharmgate Animal Health announces Deracin^®, a generic (ANADA) alternative to Aureomycin^®, has been approved by the Food and Drug Administration for use in combination with the antimicrobial Denagard^® for swine. This combination of Deracin^® (chlortetracycline) and Denagard^® (tiamulin hydrogen fumarate) is approved for the treatment of swine dysentery, enteritis and pneumonia.

“The new combination of Deracin^® and Denagard^® provides an economical, easy-to-use tool to treat sick pigs,” says Colin Gray, president and CEO of Pharmgate Animal Health. “Deracin^® gives producers and swine veterinarians a choice in chlortetracycline without the need to change treatment protocols or question how it will work.”

Deracin^® is a broad-spectrum medicated feed article (MFA) that is effective against gram-positive and gram-negative organisms that cause diseases such as enteritis, pneumonia, ileitis, leptospirosis and jowl abscesses. Deracin^® is readily absorbed via oral administration, so it quickly reaches effective blood and lung concentrations. It is a veterinary feed directive (VFD) drug to be used by or on the order of a licensed veterinarian.

Pharmgate’s pioneer NADA chlortetracycline product, Pennchlor^®, continues to be approved for combination use with Denagard^®. Like Deracin^®, Pennchlor^® is a broad-spectrum MFA and effective against gram-positive and gram-negative organisms. Pennchlor^® is highly concentrated for reduced handling and delivers versatility with a wide range of approved combinations.

“Our diverse product portfolio demonstrates our ongoing commitment to provide the industry useful, effective, high-quality products,” says Gray. “Offering both products provides producers, veterinarians and feed mills chlortetracycline treatment options.”

Ask your veterinarian or feed manufacturer to choose Deracin^® or connect with a Pharmgate representative in your area. Find bluebird labels here.

Pharmgate Animal Health is headquartered in Wilmington, North Carolina, and provides innovative and high-quality products that help the livestock industry optimize animal health, efficiency and production. Pharmgate Animal Health celebrated its 10^th anniversary in 2018.

The company’s pharmaceutical production facilities are located in Omaha, Nebraska; vaccine research and manufacturing operations are based in St. Paul, Minnesota. To learn more about Pharmgate Animal Health, visit our website at Pharmgate.com.